Contract analysis
Clause-by-clause risk read on any document of the firm. Pick a contract, or open any document from a matter.
Contract analysis / interim-covenant-compliance-tracker.xlsx
interim-covenant-compliance-tracker.xlsx
High · 1
Medium · 0
Standard · 0
[sheet: Tracker Overview]
High
⚑ Non-compete / exclusivity restraint
[sheet: Tracker Overview] Field | Detail Document Title | Interim Operating Covenant Compliance Tracker Matter Number | 1018-00008 Client | Penterra Pharmaceuticals Corp. (Nasdaq: PPCA) Target | Veridian Biosciences, Inc. Transaction | Stock Purchase Agreement — $900,000,000 Acquisition of 100% of Outstanding Capital Stock of Veridian SPA Execution Date | June 10, 2024 SPA Outside Date | December 10, 2024 Governing S